Evaluation of Plasmatic Kisspetin-10 as a Biomarker for Malignancy and Subtype Differentiation in Small Renal Tumours

Publisher： Karger

E-ISSN： 1423-0399|98|2|177-183

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.98, Iss.2, 2017-01, pp. : 177-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours

By  

HISTOPATHOLOGY, Vol. 72, Iss. 3, 2018-02 ,pp. : 441-448

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proteomics profiling of keratocystic odontogenic tumours reveals AIDA as novel biomarker candidate

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 5, 2015-05 ,pp. : 367-377

John Wiley & Sons Inc

Access to resources Recommend Favorite

Malignancy in Solitary Thyroid Nodules: Evaluation of Risk Factors

By  

Oncology Research and Treatment, Vol. 40, Iss. 6, 2017-05 ,pp. : 360-363

Karger

Access to resources Recommend Favorite

Imaging evaluation of treated benign bone tumours

By  

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, Vol. 59, Iss. 5, 2015-10 ,pp. : 599-604

John Wiley & Sons Inc

Access to resources Recommend Favorite

S100A14 is a novel independent prognostic biomarker in the triple‐negative breast cancer subtype

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 9, 2015-11 ,pp. : 2093-2103

John Wiley & Sons Inc

Access to resources Recommend Favorite